Air India suspends pilot after preliminary breathalyser test at Zurich
Air India cancelled a Zurich–Delhi flight after a pilot’s preliminary breathalyser result and has suspended the employee pending final medical and investigation reports. The case adds to scrutiny of the carrier’s flight-operations accountability measures.
What happened
Air India suspended a pilot after a preliminary breathalyser test at Zurich before a Delhi flight, which was cancelled. The airline is strengthening
Key facts
- September 6
- AI151
- September 4
- August 4
- 300 feet
- 145 people
- 24 injuries
- 36,000 feet
Why this matters
For partners and counterparties, the case heightens diligence around Air India’s operational-governance standards, safety controls, and regulatory-risk management.
What to watch
- Final medical test result and investigation findings.
- DGCA statement, notice, audit, or enforcement action.
- Disclosure of prior similar crew alcohol or fitness-for-duty incidents.
- Further flight cancellations or crew-substitution disruptions on long-haul routes.
- Evidence that station-level testing or escalation procedures were not followed.
- Passenger complaints, compensation claims, or elevated negative social-media coverage.
- Complete confirmatory medical testing and disciplinary investigation.
- Review Zurich station breathalyser, crew-reporting, and replacement-crew procedures.
- Reaccommodate disrupted Zurich–Delhi passengers and assess compensation exposure.
- Issue a limited safety-compliance update if the case attracts sustained media or regulator attention.
- Conduct targeted audits of international crew-duty, rest, and alcohol-testing controls.